Literature DB >> 19595407

RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules.

Koichi Hashimoto1, Kei Ishibashi, Ken Ishioka, Dongchi Zhao, Masatoki Sato, Shinichiro Ohara, Yusaku Abe, Yukihiko Kawasaki, Yuka Sato, Shin-Ichi Yokota, Nobuhiro Fujii, Ray Stokes Peebles, Mitsuaki Hosoya, Tatsuo Suzutani.   

Abstract

Human RSV causes an annual epidemic of respiratory tract illness in infants and in elderly. Mechanisms by which RSV antagonizes IFN-mediated antiviral responses include inhibition of type I IFN mRNA transcription and blocking signal transduction of JAK/STAT family members. The suppressor of cytokines signaling (SOCS) gene family utilizes a feedback loop to inhibit cytokine responses and block the activation of the JAK/STAT signaling pathway. To evaluate the potential of SOCS molecules to subvert the innate immune response to RSV infection, eight SOCS family genes were examined. RSV infection up-regulated SOCS1, SOCS3, and CIS mRNA expression in HEp-2 cells. Suppression of SOCS1, SOCS3 and CIS by short interfering ribonucleic acid (siRNA) inhibited viral replication. Furthermore, inhibition of SOCS1, SOCS3, or CIS activated type I IFN signaling by inducing STAT1/2 phosphorylation. These results suggest that RSV infection escapes the innate antiviral response by inducing SOCS1, SOCS3 or CIS expression in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19595407     DOI: 10.1016/j.virol.2009.06.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

Review 1.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

2.  Innate immune response to influenza A virus in differentiated human alveolar type II cells.

Authors:  Jieru Wang; Mrinalini P Nikrad; Tzulip Phang; Bifeng Gao; Taylor Alford; Yoko Ito; Karen Edeen; Emily A Travanty; Beata Kosmider; Kevan Hartshorn; Robert J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-14       Impact factor: 6.914

Review 3.  Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.

Authors:  Barney S Graham
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  A respiratory syncytial virus persistent-infected cell line system reveals the involvement of SOCS1 in the innate antiviral response.

Authors:  Junwen Zheng; Pu Yang; Yan Tang; Dongchi Zhao
Journal:  Virol Sin       Date:  2015-06-19       Impact factor: 4.327

5.  Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.

Authors:  Ashley D Frazier; Chun L Zhang; Lei Ni; Cheng J Ma; Ying Zhang; Xiao Y Wu; Antwan N Atia; Zhi Q Yao; Jonathan P Moorman
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

Review 6.  Viral exploitation of host SOCS protein functions.

Authors:  Lisa Nowoslawski Akhtar; Etty N Benveniste
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

7.  Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.

Authors:  François Michaud; François Coulombe; Eric Gaudreault; Carine Paquet-Bouchard; Marek Rola-Pleszczynski; Jean Gosselin
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

8.  Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.

Authors:  Philippa Hillyer; Rachel Shepard; Megan Uehling; Mina Krenz; Faruk Sheikh; Kalyn R Thayer; Lei Huang; Lihan Yan; Debasis Panda; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Raymond P Donnelly; Ronald L Rabin
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 9.  Interleukin-6 induces drug resistance in renal cell carcinoma.

Authors:  Kei Ishibashi; Tomoyuki Koguchi; Kanako Matsuoka; Akifumi Onagi; Ryo Tanji; Ruriko Takinami-Honda; Seiji Hoshi; Mitsutaka Onoda; Yoshimasa Kurimura; Junya Hata; Yuichi Sato; Masao Kataoka; Soichiro Ogawsa; Nobuhiro Haga; Yoshiyuki Kojima
Journal:  Fukushima J Med Sci       Date:  2018-10-23

10.  Downregulation of microRNA‑221 facilitates H1N1 influenza A virus replication through suppression of type‑IFN response by targeting the SOCS1/NF‑κB pathway.

Authors:  Nali Zhang; Yuan Ma; Yuheng Tian; Yafei Zhou; Yuhua Tang; Shaobo Hu
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.